Common Contracts

AGREEMENT AND PLAN OF MERGER entered into by and among BIOTELEMETRY, INC. PHILIPS HOLDING USA INC. and DAVIES MERGER SUB, INC. Dated as of December 18, 2020

Agreement and Plan of Merger • December 21st, 2020 • Biotelemetry, Inc. • Services-specialty outpatient facilities, nec • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  December 21st, 2020
• Company
  Biotelemetry, Inc.
• Industry
  Services-specialty outpatient facilities, nec
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of December 18, 2020, is entered into by and among BioTelemetry, Inc., a Delaware corporation (the “Company”), Philips Holding USA Inc., a Delaware corporation (“Parent”), and Davies Merger Sub, Inc., a Delaware corporation and Wholly Owned Subsidiary of Parent (“Merger Sub” and, together with the Company and Parent, the “Parties”).

AGREEMENT AND PLAN OF MERGER dated as of April 25, 2017 among ADVANCEPIERRE FOODS HOLDINGS, INC. TYSON FOODS, INC. and DVB MERGER SUB, INC.

Agreement and Plan of Merger • May 5th, 2017 • Tyson Foods Inc • Poultry slaughtering and processing • New York

• Contract Type
  Agreement and Plan of Merger
• Filed
  May 5th, 2017
• Company
  Tyson Foods Inc
• Industry
  Poultry slaughtering and processing
• Jurisdiction
  New York

AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc., a Delaware corporation (the “Company”), Tyson Foods, Inc., a Delaware corporation (“Parent”), and DVB Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”).

AGREEMENT AND PLAN OF MERGER dated as of JANUARY 11, 2015 among

Agreement and Plan of Merger • January 12th, 2015 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  January 12th, 2015
• Company
  NPS Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of January 11, 2015 among NPS Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Shire Pharmaceutical Holdings Ireland Limited, a Company incorporated in Ireland (“Parent”), Knight Newco 2, Inc., a Delaware corporation and a wholly owned direct or indirect subsidiary of Parent (“Merger Subsidiary”), and, solely for the purposes set forth in Section 12.14, Shire plc, a Company incorporated in Jersey (“Parent Holdco”).